21-44527498-C-T
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_144991.3(TSPEAR):c.943G>A(p.Val315Met) variant causes a missense change. The variant allele was found at a frequency of 0.000114 in 1,614,196 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Publications
- ectodermal dysplasia 14, hair/tooth type with or without hypohidrosisInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive nonsyndromic hearing loss 98Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_144991.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSPEAR | NM_144991.3 | MANE Select | c.943G>A | p.Val315Met | missense | Exon 7 of 12 | NP_659428.2 | ||
| TSPEAR | NM_001272037.2 | c.739G>A | p.Val247Met | missense | Exon 8 of 13 | NP_001258966.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSPEAR | ENST00000323084.9 | TSL:1 MANE Select | c.943G>A | p.Val315Met | missense | Exon 7 of 12 | ENSP00000321987.4 | ||
| TSPEAR | ENST00000397916.1 | TSL:1 | n.898G>A | non_coding_transcript_exon | Exon 7 of 11 | ||||
| TSPEAR | ENST00000642437.1 | n.*888G>A | non_coding_transcript_exon | Exon 8 of 13 | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152238Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000211 AC: 53AN: 251448 AF XY: 0.000140 show subpopulations
GnomAD4 exome AF: 0.0000746 AC: 109AN: 1461840Hom.: 1 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000492 AC: 75AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74514 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 315 of the TSPEAR protein (p.Val315Met). This variant is present in population databases (rs148421362, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with TSPEAR-related conditions. ClinVar contains an entry for this variant (Variation ID: 228056). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not specified Benign:1
Val315Met in exon 7 of TSPEAR: This variant is not expected to have clinical sig nificance because it has been identified in 0.3% (15/4406) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs148421362).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at